These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18205624)

  • 21. Affinity-based methodologies and ligands for antibody purification: advances and perspectives.
    Roque AC; Silva CS; Taipa MA
    J Chromatogr A; 2007 Aug; 1160(1-2):44-55. PubMed ID: 17618635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CroFab reconstitution in various media: an in vitro solubility study.
    Vohra R; Clark R; Kelner M
    Clin Toxicol (Phila); 2008 Nov; 46(9):808-10. PubMed ID: 18821147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation and characterization of polysulfone affinity membranes bearing a synthetic peptide ligand for the separation of murine immunoglobulins.
    Boi C; Algeri C; Sarti GC
    Biotechnol Prog; 2008; 24(6):1304-13. PubMed ID: 19194945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved process analytical technology for protein a chromatography using predictive principal component analysis tools.
    Hou Y; Jiang C; Shukla AA; Cramer SM
    Biotechnol Bioeng; 2011 Jan; 108(1):59-68. PubMed ID: 20672251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modeling of purification operations in biotechnology: enabling process development, optimization, and scale-up.
    Velayudhan A; Menon MK
    Biotechnol Prog; 2007; 23(1):68-73. PubMed ID: 17269673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mathematical and experimental analyses of antibody transport in hollow-fiber-based specific antibody filters.
    Hout MS; Federspiel WJ
    Biotechnol Prog; 2003; 19(5):1553-61. PubMed ID: 14524719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioseparation in antibody manufacturing: the good, the bad and the ugly.
    Gottschalk U
    Biotechnol Prog; 2008; 24(3):496-503. PubMed ID: 18442255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimization of adsorption conditions of papain on dye affinity membrane using response surface methodology.
    Su SN; Nie HL; Zhu LM; Chen TX
    Bioresour Technol; 2009 Apr; 100(8):2336-40. PubMed ID: 19128959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thiacarbocyanine as ligand in dye-affinity chromatography for protein purification. II. Dynamic binding capacity using lysozyme as a model.
    Boto RE; Anyanwu U; Sousa F; Almeida P; Queiroz JA
    Biomed Chromatogr; 2009 Sep; 23(9):987-93. PubMed ID: 19347966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Case study and application of process analytical technology (PAT) towards bioprocessing: use of on-line high-performance liquid chromatography (HPLC) for making real-time pooling decisions for process chromatography.
    Rathore AS; Yu M; Yeboah S; Sharma A
    Biotechnol Bioeng; 2008 Jun; 100(2):306-16. PubMed ID: 18078292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in primary recovery: centrifugation and membrane technology.
    Roush DJ; Lu Y
    Biotechnol Prog; 2008; 24(3):488-95. PubMed ID: 18410157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modeling of monolith-supported affinity chromatography.
    Montes Sanchez FJ; Martin del Valle E; Galan Serrano MA; Cerro RL
    Biotechnol Prog; 2004; 20(3):811-7. PubMed ID: 15176886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemometrics applications in biotechnology processes: predicting column integrity and impurity clearance during reuse of chromatography resin.
    Rathore AS; Mittal S; Lute S; Brorson K
    Biotechnol Prog; 2012; 28(5):1308-14. PubMed ID: 22888107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purification of human immunoglobulin G via Fc-specific small peptide ligand affinity chromatography.
    Yang H; Gurgel PV; Carbonell RG
    J Chromatogr A; 2009 Feb; 1216(6):910-8. PubMed ID: 19117576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pooling control in variable preparative chromatography processes.
    Westerberg K; Degerman M; Nilsson B
    Bioprocess Biosyst Eng; 2010 Mar; 33(3):375-82. PubMed ID: 19513758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Basic concepts in Q membrane chromatography for large-scale antibody production.
    Zhou JX; Tressel T
    Biotechnol Prog; 2006; 22(2):341-9. PubMed ID: 16599545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biomanufacturing process analytical technology (PAT) application for downstream processing: Using dissolved oxygen as an indicator of product quality for a protein refolding reaction.
    Pizarro SA; Dinges R; Adams R; Sanchez A; Winter C
    Biotechnol Bioeng; 2009 Oct; 104(2):340-51. PubMed ID: 19472303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A methodology for the comparative evaluation of alternative bioseparation technologies.
    Tran R; Zhou Y; Lacki KM; Titchener-Hooker NJ
    Biotechnol Prog; 2008; 24(5):1007-25. PubMed ID: 19194909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defining process design space for a hydrophobic interaction chromatography (HIC) purification step: application of quality by design (QbD) principles.
    Jiang C; Flansburg L; Ghose S; Jorjorian P; Shukla AA
    Biotechnol Bioeng; 2010 Dec; 107(6):985-97. PubMed ID: 20683852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.